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Dear Editor,
We read with interest the paper of Estévez, et al, recently 
published in Hepatitis Monthly (1). That article was a Letter 
to the Editor on the study conducted by Nikui Nejad et al (2). 
One of the comments made by Estévez et al was on the ad-
equacy of the size of the studied sample. They believed that 
the sample size was not adequate based on the provided 
data and the type of study (1). In the reply from the authors, 
a familiar mathematical equation which is frequently used 
for prevalence study designs was presented to explain the 
way the sample size was calculated in Nikui Nejad’s study 
(1).
In spite of doubts in the statistical analyses used in their 
study, we should emphasize that the study of Nikui Nejad, et 
al, was clearly a clinical trial involving comparison between 
two vaccines. In that study, the sample size did not depend 
on the prevalence of vaccine response rate in the popula-
tion—instead, it did depend on the difference between the 
response rates from the two vaccines. The authors also used 
an incorrect assumption for the calculation of minimum 
sample size according the “prevalence approach” and as-
sumed a large d with a small P! We know that in clinical trial, 
if the sample size is too small, a well-conducted study may 
fail to answer its research hypothesis or to detect important 
effects and associations. Therefore, correct assumptions for 
the calculation of minimum sample size are of paramount 
importance in conducting research. Approaches for estimat-
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ing sample size and performing power analysis depend pri-
marily on the study design and the main outcome measure 
(3). Clinical trials should be large enough to detect reliably 
the smallest possible differences in the primary outcomes. 
It is not uncommon for studies to be underpowered, failing 
to detect even large treatment effects because of inadequate 
sample size (4). The minimum information needed to calcu-
late sample size for a randomized controlled trial includes 
the study power (1-ß), the level of significance (α), the under-
lying event rate in the population and the effect size. The cal-
culated minimum sample size should then be adjusted for 
other factors, including expected compliance rates and, less 
commonly, an unequal allocation ratio. The objectives and 
outcome measures of the study must be clearly stated, and 
the information used in calculating the minimum sample 
size should reflect as closely as possible the type of data that 
will be gathered from the proposed trial (5). Sample size 
calculation is an important part of any clinical trials and a 
professional statistician is the best person to be asked for 
help at the time of planning a research project. However, 
researchers must be prepared to provide the necessary in-
formation so that the sample size can be determined (6). 
There are many statistical books on the methods for sample 
size calculation in medical studies (7). There are also several 
software programs available to help with sample size calcu-
lations. While these programs are easy to use, investigators 
should consult biostatisticians at the design stages of their 
projects and any article containing even the most elemen-
tary statistical procedure should be reviewed by an expert 
biostatistician.
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